儿童急性坏死性脑病治疗研究进展
Research Progress on the Treatment of Acute Necrotizing Encephalopathy in Children
DOI: 10.12677/ACM.2023.13122754, PDF,   
作者: 邓明森, 肖 农*：重庆医科大学附属儿童医院康复科，重庆；国家儿童健康与疾病临床医学研究中心，重庆；儿童发育疾病研究教育部重点实验室，重庆；儿科学重庆市重点实验室，重庆
关键词: 急性坏死性脑病；儿童；发病机制；诊断；治疗；Acute Necrotizing Encephalopathy； Children； Pathogenesis； Diagnosis； Treatment
摘要: 儿童急性坏死性脑病(acute necrotizing encephalopathy of children, ANEC)多见于病毒感染诱发，临床以意识水平迅速发生障碍、惊厥发作为主要表现，目前发病机制暂不清楚，目前普遍认为与细胞因子风暴有关，基因易感性也在发病中起到一定作用。急性坏死性脑病早期缺乏特异性临床表现，严重威胁儿童生命，目前暂无特殊治疗方式，除对症支持治疗外，控制细胞因子风暴同样重要，主要包括丙种球蛋白、糖皮质激素、IL-6阻滞剂(托珠单抗)等被用于治疗该病，早期及时控制细胞因子风暴有助于改善患儿预后，但仍遗留较高的致残率，需进一步研究对于急性坏死性脑病的治疗方式，从而提高生存率和降低致残率。
Abstract: Acute necrotizing encephalopathy in children (ANEC) is often induced by viral infection. The main clinical manifestations are rapid disturbance of consciousness and convulsion. At present, the pathogenesis is not clear. It is generally believed that it is related to cytokine storm, and genetic susceptibility also plays a certain role in the pathogenesis. Acute necrotizing encephalopathy is the lack of specific clinical manifestations in the early stage, which seriously threatens children’s life. At present, there is no special treatment. In addition to symptomatic support treatment, it is also im-portant to control cytokine storm, mainly including gamma globulin, glucocorticoid, IL-6 blocker (trozumab). Early and timely control of cytokine storm is helpful to improve the prognosis of chil-dren, but it still leaves a high disability rate. It is necessary to further study the treatment of acute necrotizing encephalopathy so as to improve the survival rate and reduce the rate of disability.
文章引用：邓明森, 肖农. 儿童急性坏死性脑病治疗研究进展[J]. 临床医学进展, 2023, 13(12): 19559-19566. https://doi.org/10.12677/ACM.2023.13122754

参考文献

[1] Wu, X., Wu, W., Pan, W., et al. (2015) Acute Necrotizing Encephalopathy: An Underrecognized Clinicoradiologic Dis-order. Mediators of Inflammation, 2015, Article ID: 792578. [Google Scholar] [CrossRef] [PubMed]
[2] Mizuguchi, M., Abe, J., Mikkaichi, K., et al. (1995) Acute Necrotising Encephalopathy of Childhood: A New Syndrome Presenting with Multifocal, Symmetric Brain Lesions. Journal of Neurology, Neurosurgery & Psychiatry, 58, 555-561. [Google Scholar] [CrossRef] [PubMed]
[3] Mizuguchi, M. (1997) Acute Necrotizing Encephalopathy of Childhood: A Novel form of Acute Encephalopathy Prevalent in Japan and Taiwan. Brain and Development, 19, 81-92. [Google Scholar] [CrossRef] 
[4] Kobayashi, Y., Kanazawa, H., Hoshino, A., et al. (2019) Acute Necrotizing Encephalopathy and a Carnitine Palmitoyltransferase 2 Variant in an Adult. Journal of Clinical Neu-roscience, 61, 264-266. [Google Scholar] [CrossRef] [PubMed]
[5] Chow, C.K. and Ma, C.K.L. (2020) Presentation and Outcome of Acute Necrotizing Encephalopathy of Childhood: A 10-Year Single-Center Retrospective Study from Hong Kong. Jour-nal of Child Neurology, 35, 674-680. [Google Scholar] [CrossRef] [PubMed]
[6] Aksoy, E., Öztoprak, Ü., Çelik, H., et al. (2021) Acute Necrotiz-ing Encephalopathy of Childhood: A Single-Center Experience. Turkish Journal of Medical Sciences, 51, 706-715. [Google Scholar] [CrossRef] [PubMed]
[7] 张涛, 王丽杰, 许巍, 等. 儿童急性坏死性脑病13例临床特点及预后随访[J]. 中华实用儿科临床杂志, 2022, 37(9): 665-670.
[8] Low, Y.Y., Lin, H.C., Wu, F.T., et al. (2021) Detec-tion of Rotavirus Antigen in a Child with Acute Necrotizing Encephalopathy. Journal of the Formosan Medical Associa-tion, 120, 1029-1031. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, P.Y., Yang, M.T. and Liang, J.S. (2022) Acute Necrotizing Encephalopathy Caused by SARS-CoV-2 in a Child. Pediatrics & Neonatology, 63, 642-644. [Google Scholar] [CrossRef] [PubMed]
[10] Ho, J.H.Y., Lee, C.Y.M., Chiong, Y.K., et al. (2023) SARS-CoV-2-Related Acute Necrotizing Encephalopathy of Childhood with Good Response to Tocilizumab in an Ado-lescent. Pediatric Neurology, 139, 65-69. [Google Scholar] [CrossRef] [PubMed]
[11] Tang, J.W., Ritchie, B., Taranath, A., et al. (2023) Case of Acute Necrotising Encephalopathy of Childhood Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 Infec-tion. Journal of Paediatrics and Child Health. [Google Scholar] [CrossRef] [PubMed]
[12] Wu, D., Zheng, Y., Li, Y., et al. (2023) Exploring the Molecular and Clini-cal Spectrum of COVID-19-Related Acute Necrotizing Encephalopathy in Three Pediatric Cases. Journal of Human Ge-netics, 68, 769-775. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, Y.J., Hwang, S.K., Lee, S.M. and Kwon, S. (2017) Familial Acute Necrotizing Encephalopathy with RANBP2 Mutation: The First Report in Northeast Asia. Brain and Development, 39, 625-628. [Google Scholar] [CrossRef] [PubMed]
[14] Aydin, H., Ozgul, E. and Agildere, A.M. (2010) Acute Ne-crotizing Encephalopathy Secondary to Diphtheria, Tetanus Toxoid and Whole-Cell Pertussis Vaccination: Diffu-sion-Weighted Imaging and Proton MR Spectroscopy Findings. Pediatric Radiology, 40, 1281-1284. [Google Scholar] [CrossRef] [PubMed]
[15] Lyon, J.B., Remigio, C., Milligan, T. and Deline, C. (2010) Acute Necrotizing Encephalopathy in a Child with H1N1 Influenza Infection. Pediatric Radiology, 40, 200-205. [Google Scholar] [CrossRef] [PubMed]
[16] Tabarki, B., Thabet, F., Al Shafi, S., et al. (2013) Acute Necrotiz-ing Encephalopathy Associated with Enterovirus Infection. Brain and Development, 35, 454-457. [Google Scholar] [CrossRef] [PubMed]
[17] Huang, W.S., Zhang, H., Wu, S., et al. (2022) A Sudden Death Due to Acute Necrotizing Encephalopathy Associated with Influenza A Virus Infection: An Autopsy Case Report. Legal Medicine, 58, Article ID: 102098. [Google Scholar] [CrossRef] [PubMed]
[18] Levine, J.M., Ahsan, N., Ho, E. and Santoro, J.D. (2020) Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics. Multiple Sclerosis and Related Disorders, 43, Article ID: 102194. [Google Scholar] [CrossRef] [PubMed]
[19] Kansagra, S.M. and Gallentine, W.B. (2011) Cytokine Storm of Acute Necrotizing Encephalopathy. Pediatric Neurology, 45, 400-402. [Google Scholar] [CrossRef] [PubMed]
[20] Hoshino, A., Takahashi, N., Oka, A. and Mizuguchi, M. (2023) Association of IL6 and IL10 Gene Promotor Polymorphisms with Susceptibility to Acute Necrotizing Encepha-lopathy. Frontiers in Neuroscience, 17, Article ID: 1231957. [Google Scholar] [CrossRef] [PubMed]
[21] Geng, C., Zhao, W., Wang, Z., et al. (2023) Acute Necrotizing Encephalopathy Associated with COVID-19: Case Series and Systematic Review. Journal of Neurology, 270, 5171-5181. [Google Scholar] [CrossRef] [PubMed]
[22] Galea, I. (2021) The Blood-Brain Barrier in System-ic Infection and Inflammation. Cellular & Molecular Immunology, 18, 2489-2501. [Google Scholar] [CrossRef] [PubMed]
[23] Catarina, A.V., Branchini, G., Bettoni, L., et al. (2021) Sep-sis-Associated Encephalopathy: From Pathophysiology to Progress in Experimental Studies. Molecular Neurobiology, 58, 2770-2779. [Google Scholar] [CrossRef] [PubMed]
[24] Huang, H., Liao, X., Zhang, A., et al. (2023) Cerebrospinal Flu-id from Patients after Craniotomy with the Appearance of Interleukin-6 Storm Can Activate Microglia to Damage the Hypothalamic Neurons in Mice. Molecular Neurobiology. [Google Scholar] [CrossRef] [PubMed]
[25] Tsao, N., Hsu, H.P., Wu, C.M., Liu, C.C. and Lei, H.Y. (2001) Tumour Necrosis Factor-α Causes an Increase in Blood-Brain Barrier Permeability during Sepsis. Journal of Medical Microbiology, 50, 812-821. [Google Scholar] [CrossRef] [PubMed]
[26] Neilson, D.E., Adams, M.D., Orr, C.M., et al. (2009) Infec-tion-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2. American Journal of Human Genetics, 84, 44-51. [Google Scholar] [CrossRef] [PubMed]
[27] Saitoh, M., Shinohara, M., Hoshino, H., et al. (2012) Mutations of the SCN1A Gene in Acute Encephalopathy. Epilepsia, 53, 558-564. [Google Scholar] [CrossRef] [PubMed]
[28] Kumakura, A., Iida, C., Saito, M., et al. (2011) Pandemic Influenza A-Associated Acute Necrotizing Encephalopathy without Neurologic Sequelae. Pediatric Neurology, 45, 344-346. [Google Scholar] [CrossRef] [PubMed]
[29] Hoshino, A., Saitoh, M., Miyagawa, T., et al. (2016) Specific HLA Genotypes Confer Susceptibility to Acute Necrotizing Encephalopathy. Genes & Immunity, 17, 367-369. [Google Scholar] [CrossRef] [PubMed]
[30] Lee, Y.J., Hwang, S.K. and Kwon, S. (2019) Acute Necrotiz-ing Encephalopathy in Children: A Long Way to Go. Journal of Korean Medical Science, 34, e143. [Google Scholar] [CrossRef] [PubMed]
[31] Albayram, S., Bilgi, Z., Selcuk, H., et al. (2004) Diffu-sion-Weighted MR Imaging Findings of Acute Necrotizing Encephalopathy. American Journal of Neuroradiology, 25, 792-797.
[32] Okumura, A., Mizuguchi, M., Kidokoro, H., et al. (2009) Outcome of Acute Necrotizing Encephalopathy in Relation to Treatment with Corticosteroids and Gammaglobulin. Brain and Development, 31, 221-227. [Google Scholar] [CrossRef] [PubMed]
[33] Chang, H.P., Hsia, S.H., Lin, J.J., et al. (2022) Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing En-cephalopathy. Children, 9, Article 136. [Google Scholar] [CrossRef] [PubMed]
[34] 王叶青, 李科纯, 杨颖, 等. 儿童急性坏死性脑病预后及影响因素分析[J]. 中华实用儿科临床杂志, 2022, 37(7): 530-533.
[35] 李科纯, 王丽杰, 刘刚, 等. 儿童急性坏死性脑病39例分析[J]. 中华儿科杂志, 2021, 59(7): 582-587.
[36] Soriano-Ramos, M., Navarro-Abia, V., Enamorado, N.N., et al. (2018) Steroids for Familial Acute Necrotizing Encephalopathy: A Future Investment? Clinical Neurology and Neu-rosurgery, 174, 134-136. [Google Scholar] [CrossRef] [PubMed]
[37] Koh, J.C., Murugasu, A., Krishnappa, J. and Thomas, T. (2019) Favorable Outcomes with Early Interleukin 6 Receptor Blockade in Severe Acute Necrotizing Encephalopathy of Child-hood. Pediatric Neurology, 98, 80-84. [Google Scholar] [CrossRef] [PubMed]
[38] Hosie, P.H., Lim, C., Scott, T.R.D., et al. (2023) Treat-ment of Severe Acute Necrotizing Encephalopathy of Childhood with Interleukin-6 Receptor Blockade in the First 24 h as Add-on Immunotherapy Shows Favorable Long-Term Outcome at 2 Years. Brain and Development, 45, 401-407. [Google Scholar] [CrossRef] [PubMed]
[39] Lee, V.W.M., Khoo, T.B., The, C.M., et al. (2023) Factors Associated with Outcomes of Severe Acute Necrotizing Encephalopathy: A Multicentre Experience in Malaysia. Devel-opmental Medicine & Child Neurology, 65, 1256-1263. [Google Scholar] [CrossRef] [PubMed]
[40] Varon, J. and Acosta, P. (2008) Therapeutic Hypothermia: Past, Present, and Future. Chest, 133, 1267-1274. [Google Scholar] [CrossRef] [PubMed]
[41] Han, H.S., Karabiyikoglu, M., Kelly, S., et al. (2003) Mild Hypothermia Inhibits Nuclear Factor-κB Translocation in Experimental Stroke. Journal of Cerebral Blood Flow & Metabolism, 23, 589-598. [Google Scholar] [CrossRef] 
[42] Vargas, W.S., Merchant, S. and Solomon, G. (2012) Favorable Outcomes in Acute Necrotizing Encephalopathy in a Child Treated with Hypothermia. Pediatric Neurology, 46, 387-389. [Google Scholar] [CrossRef] [PubMed]
[43] Sharony, R., Yu, P.J., Park, J., et al. (2010) Protein Tar-gets of Inflammatory Serine Proteases and Cardiovascular Disease. Journal of Inflammation, 7, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[44] Karnad, D.R., Bhadade, R., Verma, P.K., et al. (2014) Intravenous Administration of Ulinastatin (Human Urinary Trypsin Inhibitor) in Severe Sepsis: A Multicenter Randomized Con-trolled Study. Intensive Care Medicine, 40, 830-838. [Google Scholar] [CrossRef] [PubMed]
[45] Wang, H., Liu, B., Tang, Y., et al. (2019) Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology, 10, Article 1370. [Google Scholar] [CrossRef] [PubMed]
[46] Wakahara, K., Kobayashi, H., Yagyu, T., et al. (2005) Bikunin Suppresses Lipopolysaccharide-Induced Lethality through Down-Regulation of Tumor Necrosis Factor-α and Interleu-kin-1β in Macrophages. The Journal of Infectious Diseases, 191, 930-938. [Google Scholar] [CrossRef] [PubMed]
[47] Zhang, X., Liu, F., Liu, H., et al. (2011) Urinary Trypsin Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Blocking the Activation of p38 Mitogen-Activated Protein Kinase. In-flammation Research, 60, 569-575. [Google Scholar] [CrossRef] [PubMed]
[48] Pugia, M.J. and Lott, J.A. (2005) Pathophysiology and Diagnostic Value of Urinary Trypsin Inhibitors. Clinical Chemistry and Laboratory Medicine (CCLM), 43, 1-16. [Google Scholar] [CrossRef] 
[49] Fong, C.Y., Saw, M.T., Li, L., et al. (2021) Malaysian Outcome of Acute Necrotising Encephalopathy of Childhood. Brain and Development, 43, 538-547. [Google Scholar] [CrossRef] [PubMed]
[50] Zhu, H.M., Zhang, S.M., Yao, C., et al. (2021) The Clinical and Imaging Characteristics Associated with Neurological Sequelae of Pediatric Patients with Acute Necrotizing Enceph-alopathy. Frontiers in Pediatrics, 9, Article 655074. [Google Scholar] [CrossRef] [PubMed]
[51] Yamamoto, H., Okumura, A., Natsume, J., et al. (2015) A Severity Score for Acute Necrotizing Encephalopathy. Brain and Development, 37, 322-327. [Google Scholar] [CrossRef] [PubMed]
[52] Song, Y., Li, S., Xiao, W., et al. (2021) Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy in Children: A Retrospective Single-Center Study. Medical Sci-ence Monitor, 27, e928374. [Google Scholar] [CrossRef] 
[53] Wong, A.M., Simon, E.M., Zimmerman, R.A., et al. (2006) Acute Necrotizing Encephalopathy of Childhood: Correlation of MR Findings and Clinical Outcome. American Journal of Neuroradiology, 27, 1919-1923.
[54] Appavu, B., Foldes, S., Fox, J., et al. (2021) Treatment Timing, EEG, Neuroim-aging, and Outcomes after Acute Necrotizing Encephalopathy in Children. Journal of Child Neurology, 36, 517-524. [Google Scholar] [CrossRef] [PubMed]
[55] Wu, L., Peng, H., Jiang, Y., et al. (2022) Clinical Features and Imaging Manifestations of Acute Necrotizing Encephalopathy in Children. International Journal of Developmental Neu-roscience, 82, 447-457. [Google Scholar] [CrossRef] [PubMed]

为你推荐